FDA Extends Comment Period for Emerging Medical Device Signals Draft Guidance

January 28, 2016

On December 31, 2015, FDA released a draft guidance entitled “Public Notification of Emerging Postmarket Medical Device Signals (‘Emerging Signals’),” which stated its plans to take a more aggressive approach to reporting medical device safety warnings to the public.

When the draft guidance was initially published the FDA stated that anyone interested in providing feedback on the document would have until February 29, 2016 to do so. However, “due to the unanticipated high-level of interest from external stakeholders and the medical device community,” the Agency is extending that deadline. On Wednesday, January 27, FDA announced that interested persons will now have until March 29, 2016 to submit any comments, questions, or concerns on the draft guidance.

View our FDA News article for additional information on the contents of the draft guidance.

Are you in the process of developing a medical device? Do you have a device that needs FDA approval? We can help. Using our proprietary approach, we can help get your product through FDA cheaper, better, and faster. To learn more about our services and how we can help you, contact us today.

FDA North America

May 4, 2022

Use of Circulating Tumor Deoxyribonucleic Acid for Early-Stage Solid Tumor Drug Development; Draft Guidance for Industry; Availability

May 2022 Guidance Document Download the Final Guidance Document The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft guidance for industry entitled “Use of...

Read the Full Article
Agency Alerts General Regulatory

October 31, 2017

FDA Launches New & Improved Adverse Event Database for Drugs & Biologics

Last month, the FDA launched a new tool that allows users to search for data on the adverse events associated with drug or biological products, which was added as a dashboard to FDA’s Adverse Event...

Read the Full Article
Agency Alerts

February 24, 2016

FDA Submissions for Interoperable Medical Devices – Comment Period Extended for Draft Guidance

Additional information on FDA’s recommendations for interoperable medical devices is available in our blog post entitled “A Closer Look at FDA’s Draft Guidance Regarding Premarket Submissions for...

Read the Full Article